Schizotypy trait and striatal dopamine receptors in healthy volunteers

Psychiatry Research - Neuroimaging

Volumn 201, Issue 3, 2012, Pages 218-221

  Chen, Kao Chin ^a,c,d   Lee, I Hui ^a,c,d   Yeh, Tzung Lieh ^a,c,d   Chiu, Nan Tsing ^a   Chen, Po See ^a,c,d   Yang, Yen Kuang ^a,c,d   Lu, Ru Band ^a,c,d   Chen, Chwen Cheng ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b PFIZER INC   (United States)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Availability; Healthy volunteers; Schizotypal personality trait; Single photon emission computed tomography (SPECT); Striatal dopamine receptor

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IODOBENZAMIDE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; CORPUS STRIATUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOTYPAL PERSONALITY DISORDER; SCIZHOTYPAL PERSONALITY QUESTIONNAIRE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; CORPUS STRIATUM; FEMALE; HUMANS; IODOBENZENES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RECEPTORS, DOPAMINE; SCHIZOTYPAL PERSONALITY DISORDER; SELF REPORT; STATISTICS AS TOPIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84862789854     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.07.003     Document Type: Article

References (42)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J., Van Heertum R.L., Gorman J.M., Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:8104-8109.
2. Abi-Dargham A., Kegeles L.S., Zea-Ponce Y., Mawlawi O., Martinez D., Mitropoulou V., O'Flynn K., Koenigsberg H.W., Van Heertum R., Cooper T., Laruelle M., Siever L.J. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biological Psychiatry 2004, 55:1001-1006.
3. American Psychiatric Association DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders 1987, American Psychiatric Association, Washington, DC.
4. Asai T., Sugimori E., Tanno Y. Schizotypal personality traits and atypical lateralization in motor and language functions. Brain and Cognition 2009, 71:26-37.
5. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D., Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:2569-2574.
6. Breier A., Kestler L., Adler C., Elman I., Wiesenfeld N., Malhotra A., Pickar D. Dopamine D2 receptor density and personal detachment in healthy subjects. The American Journal of Psychiatry 1998, 155:1440-1442.
7. Brucke T., Podreka I., Angelberger P., Wenger S., Topitz A., Kufferle B., Muller C., Deecke L. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. Journal of Cerebral Blood Flow and Metabolism 1991, 11:220-228.
8. Buchsbaum M.S., Christian B.T., Lehrer D.S., Narayanan T.K., Shi B., Mantil J., Kemether E., Oakes T.R., Mukherjee J. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophrenia Research 2006, 85:232-244.
9. Catafau A.M., Bullich S., Danus M., Penengo M.M., Cot A., Abanades S., Farre M., Pavia J., Ros D. Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms. Synapse 2008, 62:62-69.
10. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science 1978, 25:638-642.
11. Chen W.J., Hsiao C.K., Lin C.C. Schizotypy in community samples: the three-factor structure and correlation with sustained attention. Journal of Abnormal Psychology 1997, 106:649-654.
12. Daneluzzo E., Bustini M., Stratta P., Casacchia M., Rossi A. Schizotypal Personality Questionnaire and Wisconsin Card Sorting Test in a population of DSM-III-R schizophrenic patients and control subjects. Comprehensive Psychiatry 1998, 39:143-148.
13. Davis K.L., Kahn R.S., Ko G., Davidson M., Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. The American Journal of Psychiatry 1991, 148:1474-1486.
14. de Haan L., Lavalaye J., van Bruggen M., van Nimwegen L., Booij J., van Amelsvoort T., Linszen D., de Haan L., Lavalaye J., van Bruggen M., van Nimwegen L., Booij J., van Amelsvoort T., Linszen D. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie 2004, 49:290-296.
15. Farde L., Gustavsson J.P., Jonsson E. D2 dopamine receptors and personality traits. Nature 1997, 385:590.
16. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., Frackowiak R.S. The relationship between global and local changes in PET scans. Journal of Cerebral Blood Flow and Metabolism 1990, 10:458-466.
17. Hirvonen J., van Erp T.G.M., Huttunen J., Aalto S., Nagren K., Huttunen M., Lonnqvist J., Kaprio J., Hietala J., Cannon T.D. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Archives of General Psychiatry 2005, 62:371-378.
18. Hori H., Nagamine M., Soshi T., Okabe S., Kim Y., Kunugi H. Schizotypal traits in healthy women predict prefrontal activation patterns during a verbal fluency task: a near-infrared spectroscopy study. Neuropsychobiology 2008, 57:61-69.
19. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia Bulletin 2009, 35:549-562.
20. Howes O.D., Montgomery A.J., Asselin M.-C., Murray R.M., Valli I., Tabraham P., Bramon-Bosch E., Valmaggia L., Johns L., Broome M., McGuire P.K., Grasby P.M. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 2009, 66:13-20.
21. Kestler L.P., Walker E., Vega E.M. Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behavioural Pharmacology 2001, 12:355-371.
22. Laruelle M. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. The Quarterly Journal of Nuclear Medicine 1998, 42:211-221.
23. Maier W., Rietschel M., Lichtermann D., Wildenauer D.B. Family and genetic studies on the relationship of schizophrenia to affective disorders. European Archives of Psychiatry and Clinical Neuroscience 1999, 249(Suppl. 4):57-61.
24. Oertel V., Knochel C., Rotarska-Jagiela A., Schonmeyer R., Lindner M., van de Ven V., Haenschel C., Uhlhaas P., Maurer K., Linden D.E. Reduced laterality as a trait marker of schizophrenia-evidence from structural and functional neuroimaging. Journal of Neuroscience 2010, 30:2289-2299.
25. Raballo A., Parnas J. The silent side of the spectrum: schizotypy and the schizotaxic self. Schizophrenia Bulletin 2011, 37(5):1017-1026.
26. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 1991, 17:555-564.
27. Raine A., Reynolds C., Lencz T., Scerbo A., Triphon N., Kim D. Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality. Schizophrenia Bulletin 1994, 20:191-201.
28. Schmitt G.J.E., la Fougere C., Dresel S., Frodl T., Hahn K., Moller H.J., Meisenzahl E.M. Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naive schizophrenic patients. Schizophrenia Research 2008, 101:133-141.
29. Schurhoff F., Laguerre A., Roy I., Beaumont J.L., Leboyer M. Handedness and schizotypal features in healthy subjects. The World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 2008, 9:121-125.
30. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987, 1:133-152.
31. Seeman P., Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7673-7675.
32. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 1998, 20:22-33.
33. Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. The American Journal of Psychiatry 1976, 133:197-202.
34. Somers M., Sommer I.E., Boks M.P., Kahn R.S. Hand-preference and population schizotypy: a meta-analysis. Schizophrenia Research 2009, 108:25-32.
35. Stefanis N.C., Vitoratou S., Smyrnis N., Constantinidis T., Evdokimidis I., Hatzimanolis I., Ntzoufras I., Stefanis C.N. Mixed handedness is associated with the Disorganization dimension of schizotypy in a young male population. Schizophrenia Research 2006, 87:289-296.
36. Stefanis N.C., Trikalinos T.A., Avramopoulos D., Smyrnis N., Evdokimidis I., Ntzani E.E., Ioannidis J.P., Stefanis C.N. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biological Psychiatry 2007, 62:784-792.
37. Toyama H., Ichise M., Ballinger J.R., Fornazzari L., Kirsh J.C. Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans. Annals of Nuclear Medicine 1993, 7:29-38.
38. Volkow N.D., Wang G.J., Begleiter H., Porjesz B., Fowler J.S., Telang F., Wong C., Ma Y., Logan J., Goldstein R., Alexoff D., Thanos P.K. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Archives of General Psychiatry 2006, 63:999-1008.
39. Vollema M.G., Hoijtink H. The multidimensionality of self-report schizotypy in a psychiatric population: an analysis using multidimensional Rasch models. Schizophrenia Bulletin 2000, 26:565-575.
40. Wong D.F., Wagner H.N., Tune L.E., Dannals R.F., Pearlson G.D., Links J.M., Tamminga C.A., Broussolle E.P., Ravert H.T., Wilson A.A., Toung J.K., Malat J., Williams J.A., O'Tuama L.A., Snyder S.H., Kuhar M.J., Gjedde A. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986, 234:1558-1563.
41. Yang Y.K., Yu L., Yeh T.L., Chiu N.T., Chen P.S., Lee I.H. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. The American Journal of Psychiatry 2004, 161:1496-1498. study, S.
42. Zakzanis K.K., Hansen K.T. Dopamine D2 densities and the schizophrenic brain. Schizophrenia Research 1998, 32:201-206.